๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Metastatic Ovarian Carcinoma

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site๐Ÿ“ Chicago Northwestern University ยท Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride Comprehensive Outcomes for After Cancer Health NCT05349227NA7 sites๐Ÿ“ Gainesville๐Ÿ“ Boston๐Ÿ“ Omaha Pack Health ยท Tests: Digital Health Coaching Program, Fitbit Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques NCT07035587n/a1 site๐Ÿ“ Seoul Yonsei University ยท Tests: Serial Blood Sampling for Molecular Profiling, One-Time Blood Sampling for Molecular Profiling CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035Phase 19 sites๐Ÿ“ Denver๐Ÿ“ Chicago๐Ÿ“ Grand Rapids Context Therapeutics Inc. ยท Tests: CT-95 Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial NCT05607329NA1 site๐Ÿ“ Hangzhou Women's Hospital School Of Medicine Zhejiang University ยท Tests: Secondary cytoreduction, Chemotherapy Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers NCT06800612n/a1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna ยท Tests: Oncologic drugs administered for treatment of breast cancer, Oncologic drug administered for treatment of gynecologic cโ€ฆ Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors NCT05969041Phase 16 sites๐Ÿ“ Darlinghurst๐Ÿ“ Randwick๐Ÿ“ Westmead Myeloid Therapeutics ยท Tests: MT-302 (A) Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial) NCT03983226Phase 25 sites๐Ÿ“ Shanghai๐Ÿ“ Guangzhou๐Ÿ“ Hangzhou Shanghai Gynecologic Oncology Group ยท Tests: Surgery, carboplatin/taxane, carboplatin/gemcitabine, cisplatin/gemcitabine, liposome doxorubicin/carboplatin..., Nirapโ€ฆ Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance NCT05704621Phase 21 site๐Ÿ“ Seoul Korea University Guro Hospital ยท Tests: secondary cytoreductive surgery, chemotherapy A Phase 1 Study of LNCB74 in Advanced Solid Tumors NCT06774963Phase 114 sites๐Ÿ“ Newport Beach๐Ÿ“ Edgewood๐Ÿ“ Boston NextCure, Inc. ยท Tests: LNCB74 Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy NCT07340164Phase 21 site๐Ÿ“ Seoul Yonsei University ยท Tests: Trastzumab Deruxtecan, Bevacizumab, Platinum Based Chemotherapy IDOV-Immune for Advanced Solid Tumors NCT06910657Phase 15 sites๐Ÿ“ St Louis๐Ÿ“ Houston๐Ÿ“ San Antonio ViroMissile, Inc. ยท Tests: IDOV-Immune (oncolytic vaccinia virus) Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers NCT05296564Phase 1, Phase 21 site๐Ÿ“ Jerusalem Hadassah Medical Organization ยท Tests: CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide, HBI 0201-ESO TCRT, Aldesleukin A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation NCT06778863Phase 121 sites๐Ÿ“ Scottsdale๐Ÿ“ Tucson๐Ÿ“ Los Angeles Clasp Therapeutics, Inc. ยท Tests: CLSP-1025 A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors. NCT07778498Phase 1, Phase 29 sites๐Ÿ“ Los Angeles๐Ÿ“ Orlando๐Ÿ“ Lake Success Phrontline Biopharma ยท Tests: TJ102 Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions NCT07883798n/a1 site๐Ÿ“ Zamoล›ฤ‡ Affidea Nu-med Center of Oncological DIagnostics and Therapy ยท Tests: Routine-care metastasis-directed radiotherapy A Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors NCT07715747Phase 11 site๐Ÿ“ Shanghai TJ Biopharma Co., Ltd. ยท Tests: TJ037130 DBC-664 in Adult Patients With Solid Tumors NCT07705035Phase 16 sites๐Ÿ“ Denver๐Ÿ“ Grand Rapids๐Ÿ“ East Brunswick Duboce Biopharmaceuticals, Inc. ยท Tests: DBC-664 Rectosigmoid Resection vs Seromuscular Tumor Shaving in Ovarian Cancer Surgery NCT04665635NA2 sites๐Ÿ“ Adana๐Ÿ“ Adana Cukurova University ยท Tests: Rectosigmoid resection A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors NCT07488676Phase 1, Phase 221 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Miami Astellas Pharma Global Development, Inc. ยท Tests: ASP546C A Study of Radspherinยฎ in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery NCT06504147Phase 210 sites๐Ÿ“ Tampa๐Ÿ“ Leuven๐Ÿ“ Roma Oncoinvent Solutions AS ยท Tests: Radspherin Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer NCT07667192n/a1 site๐Ÿ“ Zamoล›ฤ‡ Affidea Nu-med Center of Oncological DIagnostics and Therapy ยท Tests: Reirradiation, Total Ablative Strategy A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types NCT07503808Phase 115 sites๐Ÿ“ Denver๐Ÿ“ Sarasota๐Ÿ“ Detroit IDEAYA Biosciences ยท Tests: IDE034 Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer NCT07171528Phase 21 site๐Ÿ“ Goyang-si National Cancer Center, Korea ยท Tests: Secondary Cytoreductive Surgery A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors NCT07229313Phase 17 sites๐Ÿ“ Santa Monica๐Ÿ“ New Have๐Ÿ“ Camperdown Kivu Bioscience Inc. ยท Tests: KIVU-107 A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors NCT04657068Phase 1, Phase 288 sites๐Ÿ“ Birmingham๐Ÿ“ Scottsdale๐Ÿ“ Little Rock Artios Pharma Ltd ยท Tests: ART0380, Gemcitabine, Irinotecan Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites๐Ÿ“ Los Angeles๐Ÿ“ Rochester University of Southern California ยท Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors NCT06785077NA1 site๐Ÿ“ Milan European Institute of Oncology ยท Tests: buccal cells, bone marrow cells, peripheral blood cells, bone marrow biopsy Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management. NCT07451483n/a1 site๐Ÿ“ Anderlecht Jules Bordet Institute Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors NCT07523529Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: Autologous dual-target CAR-T cells selected from the predefined target library., Fludarabine, Cyclophosphamide
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy